Literature DB >> 35612782

Association of neutrophil-to-lymphocyte ratio with renal impairment among patients with acute gouty arthritis.

Kai-Jun Zhu1,2, Guo-Shu Deng1,3, Li-Yu Zhang1,3, Ye-Chun Yang1, Qiang Xu4,5, Ming-Ying Zhang6,7.   

Abstract

OBJECTIVE: Gouty arthritis (GA) is an inflammatory disease, and renal impairment may occur to varying degrees with the progress of disease. The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory marker. In this study, we aimed to explore the association between NLR and renal impairment in GA.
MATERIALS AND METHODS: The subjects comprised 499 patients with gouty arthritis (GA) (473 men, 26 women; age range, 39-61 years old) from our hospital. They were divided into a chronic kidney disease (CKD) group (n = 206) and non-CKD group (n = 293) according to the glomerular filtration rate. Blood samples were collected during the gout flares. The differences in NLR, general data, and laboratory indexes of patients with GA between the two groups were compared, such as serum uric acid (SUA), serum creatinine (SCREA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), high-density lipoprotein (HDL), and low-density lipoprotein (LDL).
RESULTS: NLR (3.38 vs. 2.38 (p < 0.001)) was higher in the CKD group, compared to the non-CKD group. Similarly, both SUA (527 vs. 507 (p < 0.05)) and SCREA (122 vs. 87 (p < 0.001)) were higher in the CKD group than in the non-CKD group. Multivariate logistic regression analysis showed that NLR (OR = 1.122, p < 0.05), age, hypertension, and SUA were risk factors for CKD in patients with GA, although HDL and HGB were protective factors. The receiver operating characteristic (ROC) curve analysis indicated that the area under the curve of NLR for predicting CKD in patients with GA was 0.646 (95% CI 0.597-0.694).
CONCLUSION: Our data showed that NLR might be an important potential factor for evaluating renal impairment in GA during flares.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Chronic kidney disease; Gouty arthritis; Neutrophil-to-lymphocyte ratio; Serum uric acid

Mesh:

Substances:

Year:  2022        PMID: 35612782     DOI: 10.1007/s11255-022-03239-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  1 in total

1.  Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?

Authors:  Nzogang K Patrice; Donkeng J Martial; Telefo P Bruno
Journal:  BMC Res Notes       Date:  2017-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.